Acinetobacter baumannii : much more than a human pathogen
Antimicrobial Agents and Chemotherapy · 03.09.2025 · 69 (9)
DOI: 10.1128/aac.00801-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.09.2025. Verfasst von Santiago Castillo-Ramírez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Mexico. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PAPIIT-UNAM, Discovery Grant NSERC Canada.
Abstract (Originalsprache)
Acinetobacter baumannii is a major human nosocomial pathogen. Due to this, a significant amount of knowledge has been gained about human clinical isolates over a substantial period of time. More recently, studies have begun to pay attention to non-human isolates of A. baumannii . In reviewing these studies, we highlight some major trends. First, A. baumannii has been found in a variety of sources/hosts: from diverse types of animals, to food products, to plants and even aquatic environments. Second, considering the molecular epidemiology of A. baumannii , two scenarios are possible. One implies transmission between human and non-human populations, and this has been described in several international clones (ICs): IC1, IC2, IC5, IC7, and IC8. In the other scenario, human populations are well differentiated from non-human populations, and there is no exchange between them. Third, in terms of antibiotic resistance in the non-human populations, these populations tend to have fewer antibiotic resistance genes, mostly intrinsic in nature. However, when non-clinical bacterial populations come into closer contact with humans, the antibiotic resistance profiles of the non-human bacterial population become more similar to those of clinical populations. Also, there are some instances of non-human isolates showing extensive drug resistance phenotypes. By far, the least studied aspect is the virulence potential of A. baumannii from non-human sources. A small number of studies suggest that some non-human isolates can be as virulent as the human isolates. Finally, we discuss gaps in knowledge and future research avenues when considering non-human populations of A. baumannii and their relationship with human populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.
- Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
- Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
- Centre for Microbial Interactions, Norwich Research Park, Norwich, United Kingdom.
ORCID-Profile: Santiago Castillo-Ramírez, Ayush Kumar
Förderung
- PAPIIT-UNAM
- Discovery Grant NSERC Canada
Zitieren
APA
Castillo-Ramírez, S., Aguilar-Vera, A., Kumar, A., & Evans, B. (2025). Acinetobacter baumannii : much more than a human pathogen. Antimicrobial Agents and Chemotherapy, 69(9). https://doi.org/10.1128/aac.00801-25
Vancouver
Castillo-Ramírez S, Aguilar-Vera A, Kumar A, Evans B. Acinetobacter baumannii : much more than a human pathogen. Antimicrobial Agents and Chemotherapy. 2025;69(9). doi:10.1128/aac.00801-25
BibTeX
@article{CastilloRamrez2025,
author = {Castillo-Ramírez, Santiago and Aguilar-Vera, Alejandro and Kumar, Ayush and Evans, Benjamin},
title = {Acinetobacter baumannii : much more than a human pathogen},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {9},
doi = {10.1128/aac.00801-25}
}
EUVIMED